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reperfusion in rats
Guangyi Liu, Jinming Song, Yunliang Guo*, Tingting Wang and Zhen ZhouAbstract
Background: Astragalus is a widely used traditional Chinese medicine and has been proven beneficial for many
aspects of human health. It is important to explore the neuroprotective effect and mechanism of astragalus
injection in cerebral ischemia reperfusion injury.
Methods: The focal cerebral ischemic model with middle cerebral artery occlusion (MCAO) reperfusion was
established by Longa’s method in healthy adult male Wistar rats, and treated by injecting intraperitoneally
astragalus injection (3 ml/kg). The neurobehavioral function of rats was evaluated by Longa’s test. The cerebral
blood flow (CBF) was measured by laser Doppler flowmetry and the cerebral infarct volume was calculated by
tetrazolium chloride (TTC) stain. The shape and structure of neurons in parahippocampal area was observed by HE
stain and the neuronal apoptosis was detected by terminal deoxynucleotidyl transferase mediated dUTP nick end
labeling (TUNEL) and flow cytometry. The expressions of c-jun N-terminal kinase 3 (JNK3) mRNA and protein were
determined by RT-PCR and immunohistochemical assay and Western blotting respectively.
Results: After treatment with astragalus injection, the expressions of JNK3 mRNA and protein reduced significantly,
the number of neuronal apoptosis minus, the cerebral infarct volume shrink, the neuronal shape-structure and
animal neurobehavioral function improved significantly than those in model rats.
Conclusions: It is suggested that astragalus injection could inhibit neuronal apoptosis, reduce infarct volume and
improve neurobehavioral function by down-regulating the expression of JNK3 gene after cerebral ischemia
reperfusion injury in rats.
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Neuronal apoptosis in ischemic penumbra is one of the
mechanisms of neuronal damage in ischemic cerebro-
vascular disease [1]. The c-jun amino terminal kinase
(c-Jun N-terminal kinase, JNK) signaling is an important
pathway of mitogen-activated protein kinase (MAPK) [2]
and plays an important regulatory role in programmed
cell death [3]. The encoding JNK genes found presently
in mammalian cells included jnk1, jnk2 and jnk3, and
their corresponding coding product JNK1 and JNK2* Correspondence: guoqdsd@163.com
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reproduction in any medium, provided the orexpressed widely, while JNK3 expressed only in brain,
heart and testicular tissues [4]. JNK3 is the key signal in
neuronal apoptosis during brain ischemia [5], and the
JNK3 gene knockout not only reduce the c-jun phos-
phorylation but also protect the brain injury caused by
cerebral ischemia/hypoxia [6], so that inhibiting JNK3
expression and neuronal apoptosis maybe one of import-
ant methods to prevent and treat cerebral ischemic in-
jury [7]. Iijima et al. [8] reported that propofol (propofol
was originally developed in the UK by Imperial Chemical
Industries as ICI 35868. Wikipedia® is a registered trade-
mark of the Wikimedia Foundation, Inc.) could get rid
of free radicals in the body, improve cerebral bloodThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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campus caused by ischemia in rats [9]. Previous experi-
ments shown some ingredients of traditional Chinese
medicine have neuroprotctive role [10,11]. Qu et al.
[12,13] reported that astragaloside, a main ingredient of
astragalus injection, could decrease leukocyte infusion in
cerebral ischemia reperfusion tissue, and reduce inflam-
matory reaction and brain edema. The research results of
Ye et al. [14,15] indicated that astragalus injection could
inhibit the apoptosis-associated gene JNK3 expression, but
its neuroprotective mechanism is not very clear now
[16,17]. This work aims further to study the influence of
astragalus injection on the expression of JNK3 and neur-
onal apoptosis following cerebral ischemia reperfusion in-
jury, as well as its neuroprotective mechanism.
Methods
Establishment of animal models
Total of 70 healthy adult male Wistar rats (SPF grade
with 4 months age and 203-250 g body weight) were
supplied by the Laboratory Animal Center of Qingdao
Drug Inspection, the license number is SCXK (Lu)
20090007. The disposition on animals in the experi-
ments are in accordance with the relevant provisions of
the guidance to take care of the experimental animals is-
sued by the Science and Technology Department of the
People’s Republic of China (The Ministry of Science and
Technology of the People’s Republic of China: Guidance
Suggestions for the Care and Use of Laboratory Animals. ;
2006). Of which 20 rats (n = 20) were randomly selected
as control group and the rest 50 rats were established focal
cerebral ischemic models by inserting intraluminaly a
monofilament suture into middle cerebral artery from
external-internal carotid artery according to Longa’s
methods [18]. After ischemia 2 h, the monofilament
thread was withdrawn to re-perfuse blood flow, and the
rats in control group was subjected the same surgical op-
eration without inserting a monofilament suture. Core
body temperature was maintained at 36–37°C using a
electric homeothermic blanket during and after the oper-
ation, and the cerebral blood flow (CBF) in parietal cortex
was continuously monitored with laser Doppler flowmetry
(PeriFlux 5000, Sweden). The rat was considered as a suc-
cessful model when its CBF reduced to 30% and Horner’s
sign appeared with right forelimb flexing and circling
rightward as running. Of which 10 rats died or unsuccess-
ful models, and the rest 40 successful models were
subdivided randomly into model group (n = 20) and treat-
ment group (n = 20).
Treatment
Astragalus injection (No. Z31020084) is provided by
Chengdu Diao Jiuhong Pharmacy Co., Ltd. Each milliliter
(ml) astragalus injection contained 1 mg astragaloside(molecular weight: 784.97, molecular formula: C41H68
O14). According to the treatment dose reported by Liu
et al. [19], the rats in treatment group were intraperitone-
ally injected astragalus injection (3 ml/kg or 3 mg/kg) at




After treatment 24 h with astragalus injection, the
neurobehavioral function was evaluated according to
Longa’s test [18]. Score 0: no behavioral deficiency; Score
1: the rat’s forelimb flexioned when its tail was lifted sus-
pension; Score 2: lateral thrust resistance decreased (lat-
eral thrust test positive) and forelimb flexioned when tail
lifted; Score 3: the same as midrange behavior and circ-
ling spontaneously. The higher score, the severe neuro-
logical function deficiency.
Cerebral blood flow (CBF)
CBF of the lateral hemisphere (parietal cortex) was con-
tinuously monitored with laser Doppler flowmetry. The
head of laser fiber was placed stereotactically (SN-3,
Narishige, Tokyo, Japan) in the area known to be ische-
mia after MCAO by a stainless cannula (the right caud-
ate anterior 18.0 mm, right 8.0 mm, and height 18.0 mm
according to an atlas. The rat CBF was recorded by
Perisoft ware and calculated by CBF index (CBFI%) =
(CBF of ischemic side / CBF of contralateral side) × 100.
Cerebral infarct volume (CIV)
After treatment 24 h with astragalus injection, 5 rats in
each group were randomly selected and anesthetized
with 10% chloral hydrate 0.3 ml (300 mg/kg) to be
sacrificed by cutting the neck. The brain was removed
rapidly and take out completely to be cut into five
coronal sections of 2 mm thickness backward from
optic chiasma. Then the sections were immersed in 2%
2, 3, 5-triphenyltetrazolium chloride (TTC) at 37°C for
10 min. The normal brain tissue showed red and infarct
tissue white. The CIV is determined by Adobe Photo-
Shop CS after taking a photograph and presented as the
percentage (%) of (cerebral infarct area / contralateral
hemisphere area) × 100.
Histopathology: After treatment 24 h with astragalus
injection, 5 rats in each group were anesthetized with
10% chloral hydrate and perfused from heart with
200 ml of normal saline and 200 ml of 4% paraformalde-
hyde solution. The brain was removed and dehydrated
by gradient ethanol, cleared by xylene, embedded in par-
affin and cut coronally backward from optic chiasma
into pieces of thickness 5 μm, then adhered to the glass
slices, and finally stored at 4°C. Four paraffin sections
from each rat were selected to stain with hematoxylin
Table 1 Longa’s test scales and CBFI of rats (Mean ± SD)
Groups n Longa’s test scales CBFI (%)
Control group 20 0.00 ± 0.00 3.53 ± 1.13
Model group 20 2.25 ± 0.45* 73.25 ± 5.45*
Treatment group 20 1.553 ± 0.35△# 81.50 ± 6.30△#
Compared with control group, *t = 30.26-30.82, P < 0.01; △t = 18.10-27.30,
P < 0.01; #Compared with model group, t = 7.57-6.11, P < 0.01.
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nol for 30s, and stained by acidification eosin for 1 min.
The neuron morphology in parietal cortex was observed
in four non-overlapping visual fields under light micro-
scope and presented as degenerative cell index (DCI):
the number of degenerative cells / total cells in the vis-
ual field (Mean ± SD).
Neuronal apoptosis
According to the instruction of TUNEL apoptosis detec-
tion kit (Wuhan Boster Biotech. Co. Ltd., China), four
paraffin sections form each group were conventionally
de-waxed and hydrated to dispose with 3% H2O2 for
10 min at room temperature, and then digested by pro-
teinase K (1:200) for 10 min at 37°C. Mixing TdT (1 μl)
and Dig-dUTP (1 μl) into labeling buffer (18 μl) and add
on each paraffin slice to react for 2 h at 37°C. Add biotin
anti-digoxin antibody (1:100) and react for 30 min at
37°C, then add SABC (1:100) to react for 30 min at 37°C
and colored with HRP-DAB reagent kit (Beijing Tiangen
Biotech. Co. Ltd.). The TUNEL positive cells showed
orange-brown nuclei under light microscope (Olympus
CK2, Japan). Under high magnification (400 times), four
non-overlapping visual fields in hippocampal area were
randomly selected from each section to calculate the
neuronal apoptosis index (NAI). NAI = the number of
TUNEL-positive cells / the number of total cells in the
field. Mean ± SD.
Immunohistochemical assay
The rabbit anti-rat JNK3 antibody and immunohisto-
chemical SP kit (Wuhan Boster Biotech. Co. Ltd.) were
used to detect the expression JNK3 in parietal cortex.
Referring to the instructions of kit, four sections formFigure 1 The cerebral infarction volume of rats detected by TTC staineach group were de-waxed and hydrated to dispose 3%
H2O2 for 10 min at room temperature. Added JNK3
antibody (1:100) to react for 2 h at 37°C and SP (1:100)
to incubate at 37°C for 30 min, and colored with HRP-
DAB. The JNK3 positive cells appeared brown cytoplasm
and measured by UV spectrophotometer (Beckmann
USA) in four non-overlapping visual fields in each sec-
tion. The JNK3 expression intensity was presented by
relative absorbance (A) index (RAI): the A value of JNK3
positive cells minus the background A value, Mean ± SD.
Flow cytometry
After treatment 24 h with astragalus injection, 5 rats in
each group were anesthetized with 10% chloral hydrate
and perfused from heart with 200 ml of normal saline.
Then remmoved the whole brain and put in the distilled
cool water, peeled off the vessel and membranous tis-
sues, and removed left parahippocampal tissue weighting
100 mg. According to the instruction of Annexin
V-FITC apoptosis detection kit (Nanjing Biotech. Co.
Ltd.), flow cytometry analysis was operated by FACScan
Calibur (BD Company, USA) within 1 h and the result
of neuronal apoptotic ratio (NAR%) was calculated by
CELL Quest program analysis.
Western blotting
After treatment 24 h with astragalus injection, 5 rats
from each group were deeply anesthetized and perfused
with normal saline. The whole brain was frozen in liquid
nitrogen at −80°C and separated left parahippocampal
tissue weighting 100 mg to grind with RIPA lysis buffer
100 μl at 4°C. After ultrasonic slurry and centrifuged
with 12000 r/min for 10 min at 4°C (Eppendorf 5801,
Germany), the supernatant was collected to determine
the total protein concentration by BCA-100 kit. Took
protein sample 50 μg to subject to electrophoresis on
10% SDS-polyacrylamide gels (SDS-PAGE) and trans-
ferred onto PVDF membrane (Millipore, Bedford, MA,
USA) using a semi-dry electrophoretic transfer system.
The PVDF membrane were blocked for 1 h at room
temperature and then incubated with the primary goat
anti-rat JNK3 antibody (1:300) overnight at 4°C. Finally. A. Control group, B. Model group, C. Treatment group
Figure 2 The cellular shape and structure in parahippocampal area of rats, HE staining × 400. (A) Control group: neurons arrange neatly,
cell structure is completely. (B) Model group: neurons arranged disorderly, cytoplasm and nucleolus dyed deeply. (C) The number of degenerated
cells (→) reduced than that of model group.
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developed an image for 40s, fixed 2 min, washed 5 min
and dried at room temperature. The absorbance (A)
value of each band was determined by Quantity One
software. In the same specimen, the value of 3-glyceral-
dehyde-phosphate dehydrogenase (GAPDH) was also
detected to calibrate the concentration of each target
protein. The relative A value (RAV) was calculated as
follows: the A value of JNK3 / the A value of GAPDH.
RT-PCR
The above frozen sample was homogenized in Trizol re-
agent (Life Tech, USA) using 1 ml of Trizol per 50 mg
of tissue. Total RNA was extracted from the tissue
according to the manufacturer’s protocol and calculated
the purity by A260/280 nm spectrophotometer. Using
RT-PCR kit (Invitrogen, USA, USA), cDNA was synthe-
sized from total RNA (5 μg). JNK3 sense primer: 5’-CTG
ATG CAG TGC ACG ATC TAC-3’, anti-sense primer:
5’-AGC GTC GTA CTA GAC GTT GCG AT-3’, the
product: 197 bp. GAPDH sense primer: 5’-TAG TCT
ACA TGC TGC AGT ACT ACT-3’, anti-sense primer:
5’-CGA CTT GAT GTT AGC GAG ATA TC -3’ the
product: 225 bp. PCR cycling conditions with reference
to the use of JNK3 mRNA kit (Stanta Cruz, USA), 95°CFigure 3 Apoptotic neurons in hippocampal CA2 area detected by TU
→ apoptotic neuronspredegeneration for 3 min; at 94°C modified for 30s;
56°C for 30s. 72°C for 40s, for 30 cycle. Finally extension
at 72°C for 3 min. The experiment is repeated 3 times
with a 2% agarose gel electrophoresis of PCR products,
and visualized under ultraviolet illumination by ethidium
bromide (EB) staining. The A value of each mRNA band
in the same gel was captured and determined through
Scion analysis software. The relative A value (RAV) of
JNK3 mRNA were presented as: the A value of JNK3 /
the A value of GAPDH.
Statistical analysis
The experimental results were adopted to the analysis of
SPSS15.0 software (SPSS, Chicago, IL, USA). The experi-
mental data was showed in (means ± SD), and we use
single factor for analysis of variance between groups,
LSD-t test for comparing in pairs.
Results
Neurobehavioral function
The neurobehavioral function of rats in control group
was normal and Longa’s test was 0 scales. The Longa’s
test scales of rats in model group were significantly
higher than those in control group (t = 30.82, P < 0.01),
while in treatment group decreased significantly thanNEL × 400. A. Control group, B. Model group, C. Treatment group.
Figure 4 Neuronal apoptotic ratio (NAR) in parahippocampal area detected by flow cytometry. A: Control group, B. Model group,
C. Treatment group
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than those in control group (t = 27.30, P < 0.01) (Table 1).
Cerebral blood flow
The cerebral blood flow index (CBFI%) of rats in control
group was 100, which in model group (73.25 ± 5.45) re-
duced significantly (t = 30.26, P < 0.01), while in treat-
ment group (81.60 ± 6.30) was significantly higher than
that in model group (t = 6.11, P<0.01) and also lower
than that in control group (t = 18.10, P < 0.01) (Table 1).
Cerebral infarct volume
The normal brain tissues showed red and the infarct
brain tissue showed white (Figure 1). No cerebral infarct
area was found in the brain tissue of control group rats
(CIV = 0), while a large infarct volume (CIV = 70.50 ±
6.75) existed in model group, and CIV reduced to 45.35
± 5.62 in treatment group significantly (t = 8.11, P<0.01).
The pathology in parahippocampal area
Hematoxylin-eosin (HE) staining (Figure 2) showed that
the neurons in parahippocampal area arranged neatly,
the cellular structure was completely, and the degenera-
tive cell index (DCI) was 022 ± 0.07. In model group, theFigure 5 The expression of JNK3 in parahipppocampal area, SP staini
was completely. (B) Model group: neurons arranged disorderly, the numbe
the number of JNK3-positive neurons (→) decreased significantly.neurons degenerated seriously with triangular or irregu-
lar shape, the cytoplasm and nucleus concentrated, and
the DCI (0.56 ± 0.20) was higher than that in control
group (t = 4.54, P<0.01). In treatment group, the DCI
(0.33 ± 0.14) was significantly lower than that in model
group (t = 2.43, P<0.05) and also higher than that in con-
trol group (t = 2.35, P < 0.05).
Neuronal apoptosis in parahippocampal area
TUNEL staining (Figure 3) showed that a few apoptotic
neurons existed in control group (NAI = 0.12 ± 0.02).
The number of apoptotic neurons in model group
(NAI = 0.33 ± 0.07) increased significantly than that in
control group (t = 8.16, P < 0.01), while decreased signifi-
cantly in treatment group (NAI = 0.26 ± 0.04) than that
in model group (t = 2.46, P < 0.05), and also higher than
that in control group (t = 8.86, P < 0.01).
Flow cytometry (Figure 4) indicated that neuronal
apoptotic ratio (NAR) in model group (6.56 ± 1.65) in-
creased significantly than that in control group (1.67 ±
0.35) (t = 8.20, P < 0.01). In treatment group, the NAR
(4.35 ± 1.12) decreased obviously than that in model
group (t = 3.13, P < 0.01) and also higher than that in
control group (t = 6.46, P < 0.01).ng × 400. (A) Control group: neurons arranged neatly, cell structure
r of JNK3-positive neurons increased significantly. (C) Treatment group:
Figure 6 The fragmentation formed by JNK3 protein detected by Western blotting. Line 1: a weaker fragment was formed by JNK3 protein
in control group. Line 2: a strong fragment was formed by JNK3 protein in model group. Line 3: a middle fragment was formed by JNK3 protein
in treatment group.
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Immunohistochemical staining (Figure 5) showed that
the expression of JNK3 in parahippocampal area of con-
trol group (RAI = 0.14±0.05) was slightly, which in-
creased significantly in model group (RAI = 0.37± 0.12)
than that of control group (t = 5.00, P < 0.01), while re-
duced obviously in treatment group (RAI = 0.26 ± 0.08)
than that of model group (t = 2.15, P < 0.05) and also
higher than that in control group (t = 3.59, P < 0.01).
Western bloting of quantitative analysis (Figure 6) in-
dicated that JNK3 (11kD) expressed slightly in control
group (RAV = 0.33 ± 0.08), and increased significantly in
model group (RAV = 0.87 ± 0.21) than that in control
group (t = 6.84, P < 0.01), while reduced obviously in
treatment group (RAV = 0.56 ± 0.14) than that in model
group (t = 3.54, P < 0.01) and also higher than that in
control group (t = 4.04, P < 0.01).
The expression of JNK3 mRNA
The relative A values of JNK3 and GAPDH presented
the relative content of PCR products (Figure 7). The
JNK3 mRNA in control group (RAV = 0.33 ± 0.07)
expressed slightly and expressed significantly in model
group (RAV = 0.93 ± 0.21) stronger than that in control
group (t = 7.67, P < 0.01), while decreased obviously in
treatment group (RAV = 0.67 ± 0.17) than that in modelFigure 7 Electrophoresis analysis of RT-PCR products of JNK3 mRNA (
control group; Line 3–4: strong light bands in model group; Line 5–6: middgroup (t = 2.72, P < 0.01) and also higher than that in
control group (t = 6.26, P < 0.01).
Discussion
Cerebral ischemia and reperfusion can induce the ex-
pression of apoptosis-related genes c-jun N-terminal
kinase 3 (JNK3) to cause neuronal apoptosis [20]. It is
the main purpose of treatment that re-canalizing the oc-
cluded artery early as soon as possible for the regional
blood supply in ischemic penumbra to save neurons’
functions [21]. The main direction of the current treat-
ment is how to prevent the delayed neuronal death to
rescue ischemic penumbra [22]. JNK3 is located in the
cytoplasm of neurons, which is activated by cerebral is-
chemia reperfusion injury and transferred into the nu-
cleus, and then activates the other transcription factors
c-Jun and Jun D. The activated transcription factors (e.g.
c-Jun and Jun D) combined with cis-actingelement to
cause a large number of gene expressions associated
apoptosis, which related closely to delayed cell death
[23-25]. Kuan et al. [5] reported that JNK3 is the key sig-
nal in neuronal apoptosis during brain ischemia, so
inhibiting JNK3 expression conuld reduce neuronal
apoptosis and treat cerebral ischemic injury [7]. Ren
et al. [26] reported that astragalus could (1) eliminate
free radicals and avoid lipid peroxidation to improveleft) and GAPDH (right). M: Maker; Line 1–2: weak light bands in
le light bands in treatment group
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amino acid and restrain the expression of heat shock
protein 70 and alleviate the cerebral ischemic injury, (3)
reduce the permeability of blood vessel and improve of
hemorrheology after ischemia, (4) restrain the hyper-
normic expression of glial fibrillary acidic protein in
early period of cerebral ischemia and inhibit neuronal
apoptosis effectively. Ye et al. [14] reported that astrag-
alus injection could inhibit neuronal apoptosis and
expression of JNK3 after hypoxia/hypoglycemia and
re-oxygenation in hippocampal neurons.
In this experiment, the results show that the expres-
sions of JNK3 mRNA and protein increased significantly
after cerebral ischemia reperfusion to induce neuronal
apoptosis, neuronal degeneration and cerebral infarction,
which caused disorder in neurobehavioral function
disorderly. In model group, RT-PCR results indicated
that JNK3 mRNA expressed significantly and immuno-
histochemical staining and quantitative Western blotting
showed JNK3 protein was expressed more than in con-
trol group. At the same time, TUNEL assay and flow
cytometry also showed neuronal apoptosis highly, and
hematoxylin-eosin staining showed neuronal degener-
ation seriously with large ischemic infarction and
neurobehavioral dysfunction of rats. These results fur-
ther indicated that cerebral ischemia caused JNK3 ex-
pression to inducing neuronal apoptosis and nervous
dysfunction. After treatment with astragalus injection,
the expressions of JNK3 mRNA and JNK3 protein of
parahippocampal area decreased significantly than those
in model group, so reduced the JNK3 protein activity
and inhibited neuronal apoptosis, and as a results, re-
duced the cerebral infarction volume and improved the
neuronal structure and neurobehavioral function of rats.
Our research results were coincident with the previous
reported [27,28], which further suggested that astragalus
injection could inhabit neuronal apoptosis in ischemic
area, reduce the cerebral infarct volume and improve
the neurobehavioral function of rats. It might be the
molecular mechanism of astragalus reducing JNK3
expression and inhibiting neuronal apoptosis to recover
neuronal structure and function of rats after cerebral is-
chemia reperfusion injury.
Conclusions
Astragalus injection could reduce infarction volume and
improve neurobehavioral function by reducing the ex-
pression of JNK3 gene to inhibit neuronal apoptosis fol-
lowing cerebral ischemia in rats.
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